Vaccines Clinical Trials

Chandler : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Mesa : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tucson : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Jonesboro : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Little Rock : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Paramount : Center for Clinical Trials, LLC

SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.

View More »

Fresno : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Hayward : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Huntington Beach : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Loma Linda : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Moreno Valley : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Paramount : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Sacramento : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

San Diego : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

San Diego : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Valley Village : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Denver : Radiant Research - Denver

Meningitis Vaccine Research Study

Longmont : Longmont Medical Research Network

Investigational Combination Vaccine Study for Ages 4 through 6

View More »

Colorado Springs : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Denver : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research for Flu Vaccine

Pinellas Park : Radiant Research - St. Petersburg

Flu Vaccine Research Study

Pinellas Park : Radiant Research - St. Petersburg

Flu Vaccine Research Study

Tampa : Tampa Clinical Research

Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.

View More »

South Miami : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Tampa : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Atlanta : Radiant Research - Atlanta

Meningitis Vaccine Research Study

Savannah : Southeast Regional Research Group - Savannah

Southeast Regional Research Group is conducting a small pox vaccine research trial

Stockbridge : Clinical Research Atlanta

Hepatitis B vaccine for adults with type II diabetes.

View More »

Atlanta : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Dalton : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Marietta : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Marietta : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Woodstock : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Woodstock : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Meridian : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

DeKalb : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Council Bluffs : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Wichita : Wichita Clinic, PA

Clinical Research Trial studying Rheumatoid Arthritis Therapy and Vaccines

Wichita : Via Christi Research

Safety, Tolerance & Immunogenic Response to Vaccine for MCV4, TDaP & Bivalent rLP2086 in Children 10-12

View More »

Augusta : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Wichita : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Lexington : University of Kentucky Chandler Medical Center

Healthy Adult Volunteers Needed for Vaccine Research

Lexington : Central Kentucky Research Associates

Melanoma Vaccine

View More »

Bardstown : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Bardstown : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Lexington : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Louisville : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Stevensville : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Edina : Radiant Research - Minneapolis

Vaccine Research

St. Louis : Radiant Research - St. Louis

A Clinical Research Study for Meningitis Vaccine (People 56+)

St. Louis : Radiant Research - St. Louis

Clinical Research for Vaccine (Measles, Mumps, Rubella)

St. Louis : Radiant Research - St. Louis

Flu Vaccine Research Study

View More »

Kansas City : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

St. Louis : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Fremont : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Lincoln : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Omaha : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Henderson : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Mineola : Winthrop University Hospital Clinical Trials Center

Pediatric Meningococcal Vaccine

Mineola : Winthrop University Hospital Clinical Trials Center

Preventative vaccine

View More »

East Syracuse : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Syracuse : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Charlotte : Piedmont Medical Research

The Flu Stinks, So Protect Yourself!

Raleigh : Wake Research Associates

Melanoma Vaccine

View More »

Durham : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Raleigh : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Raleigh : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Fargo : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Cleveland : Rapid Medical Research, Inc. (RMR)

HELP US RESEARCH FOR THE FUTURE - We need healthy volunteers to participate in this important medical research.

Cleveland : Rapid Medical Research, Inc. (RMR)

Meningitis Vaccine Study: What is Meningococcal Disease Type B?

View More »

Akron : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Cincinnati : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Cincinnati : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Cleveland : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Huber Heights : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Kettering : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Norman : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Norman : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Oklahoma City : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tulsa : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Tulsa : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Philadelphia : Clinical Research of Philadelphia, LLC

HPV Vaccine Research Study

View More »

Carnegie : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Cranston : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Warwick : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Anderson : Radiant Research - Anderson

Flu Vaccine Research Study

Anderson : Radiant Research - Anderson

Meningitis Vaccine (Pediatric) Research Study

Anderson : Radiant Research - Anderson

What's News @ Radiant Research Anderson

Mt. Pleasant : PMG Research of Charleston

Clinical Trial for Smallpox Vaccine Now Enrolling

Mt. Pleasant : Coastal Carolina Research Center Updated

Flu Vaccine Study - Aged 65 years of age or older? Volunteers needed for an investigational flu vaccine research study.

Mt. Pleasant : Coastal Carolina Research Center

Healthy volunteers (ages 10 to 25) needed for vaccine research study for prevention of meningitis

Mt. Pleasant : Coastal Carolina Research Center

Healthy volunteers needed for Biodefense/Anthrax vaccine research study.

Mt. Pleasant : Coastal Carolina Research Center Updated

Pandemic Bird Flu Vaccine Research Study - Healthy Volunteers aged 18 to 64

View More »

Anderson : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Charleston : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Mount Pleasant : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Nashville : Clinical Research Associates, Inc.

Adolescent Vaccine Study

Nashville : Clinical Research Associates, Inc.

Flu Vaccine

Nashville : Clinical Research Associates, Inc.

HPV Vaccine for ages 16-26

View More »

Bristol : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Nashville : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Dallas : Research Across America

Healthy Volunteer Vaccine Research Study

Dallas : Research Across America

Meningococcal Vaccine Research Study

Houston : DM Clinical Research

An investigational vaccine study that would limit the amount of shots given.

Houston : DM Clinical Research

Pediatric Meningitis Vaccine- Houston,TX

Houston : DM Clinical Research

Pediatric RSV Vaccine- Houston,TX

San Antonio : Lung Diagnostics, LTD

Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)

View More »

Austin : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Austin : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Dallas : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Houston : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

San Antonio : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Tomball : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Bountiful : Pharmaceutical Research Organization

If you have a healthy child 9 months to 15-18 months, we invite you to see if he or she may qualify for a medical research study to determine how the Menactra vaccine interacts with Pentacel.

Murray : Radiant Research - Salt Lake City

Meningitis Research Study

Salt Lake City : J. Lewis Research, Inc.

MMR Vaccine (12-15 months)

Salt Lake City : J. Lewis Research, Inc.

Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes

South Jordan : J. Lewis Research, Inc.

MMR Vaccine

South Jordan : Jordan River Family Medicine

MMR Vaccine

West Jordan : Advanced Clinical Research, UT

Has Your Child Received a Meningitis Vaccine?

View More »

Murray : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Salt Lake City : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

South Jordan : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

West Jordan : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Burke : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Charlottesville : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Vancouver : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Vancouver : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

La Crosse : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Monroe : Pfizer Investigational Site Updated

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Montreal : Pfizer Investigational Site Updated

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Sherbrooke : Pfizer Investigational Site Updated

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Toronto : Pfizer Investigational Site Updated

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.